02:27 PM EST, 03/06/2024 (MT Newswires) -- WAVE Life Sciences ( WVE ) shares surged more than 32% in recent Wednesday trading after the company reported better-than-expected Q4 results.

Earlier, the company posted a Q4 loss of $0.15 per diluted share, narrower than a loss of $0.47 a year earlier.

Analysts surveyed by Capital IQ expected a loss of $0.23.

Revenue for the quarter ended Dec. 31 was $29.1 million, up from $1.2 million a year earlier.

Analysts surveyed by Capital IQ expected $19.8 million.

Price: 6.35, Change: +1.55, Percent Change: +32.46